Form 10-Q - Quarterly report [Sections 13 or 15(d)]

0001352952 --12-31 false 2024 Q2 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 0001352952 2024-01-01 2024-06-30 0001352952 2024-06-30 0001352952 2024-08-12 0001352952 2023-12-31 0001352952 us-gaap:SeriesAPreferredStockMember 2024-06-30 0001352952 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001352952 us-gaap:SeriesBPreferredStockMember 2024-06-30 0001352952 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001352952 2024-04-01 2024-06-30 0001352952 2023-04-01 2023-06-30 0001352952 2023-01-01 2023-06-30 0001352952 2022-12-31 0001352952 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001352952 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001352952 us-gaap:CommonStockMember 2022-12-31 0001352952 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001352952 us-gaap:RetainedEarningsMember 2022-12-31 0001352952 2023-01-01 2023-03-31 0001352952 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001352952 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001352952 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001352952 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001352952 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001352952 2023-03-31 0001352952 us-gaap:SeriesAPreferredStockMember 2023-03-31 0001352952 us-gaap:SeriesBPreferredStockMember 2023-03-31 0001352952 us-gaap:CommonStockMember 2023-03-31 0001352952 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001352952 us-gaap:RetainedEarningsMember 2023-03-31 0001352952 us-gaap:SeriesAPreferredStockMember 2023-04-01 2023-06-30 0001352952 us-gaap:SeriesBPreferredStockMember 2023-04-01 2023-06-30 0001352952 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001352952 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001352952 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001352952 2023-06-30 0001352952 us-gaap:SeriesAPreferredStockMember 2023-06-30 0001352952 us-gaap:SeriesBPreferredStockMember 2023-06-30 0001352952 us-gaap:CommonStockMember 2023-06-30 0001352952 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001352952 us-gaap:RetainedEarningsMember 2023-06-30 0001352952 us-gaap:CommonStockMember 2023-12-31 0001352952 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001352952 us-gaap:RetainedEarningsMember 2023-12-31 0001352952 2024-01-01 2024-03-31 0001352952 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0001352952 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-03-31 0001352952 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001352952 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001352952 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001352952 2024-03-31 0001352952 us-gaap:SeriesAPreferredStockMember 2024-03-31 0001352952 us-gaap:SeriesBPreferredStockMember 2024-03-31 0001352952 us-gaap:CommonStockMember 2024-03-31 0001352952 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001352952 us-gaap:RetainedEarningsMember 2024-03-31 0001352952 us-gaap:SeriesAPreferredStockMember 2024-04-01 2024-06-30 0001352952 us-gaap:SeriesBPreferredStockMember 2024-04-01 2024-06-30 0001352952 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001352952 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001352952 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001352952 us-gaap:CommonStockMember 2024-06-30 0001352952 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001352952 us-gaap:RetainedEarningsMember 2024-06-30 0001352952 fil:AssetPurchasedAgreementWithEmergingGrowthLlcMember 2019-05-15 2019-05-15 0001352952 us-gaap:CommonStockMember 2019-05-15 2019-05-15 0001352952 us-gaap:SeriesBPreferredStockMember 2019-05-15 2019-05-15 0001352952 2019-05-15 2019-05-15 0001352952 us-gaap:AccountsReceivableMember 2024-01-01 2024-06-30 0001352952 us-gaap:SalesRevenueNetMember 2024-04-01 2024-06-30 0001352952 us-gaap:SalesRevenueNetMember 2024-01-01 2024-06-30 0001352952 us-gaap:ServiceMember 2024-01-01 2024-06-30 0001352952 us-gaap:ServiceMember 2024-04-01 2024-06-30 0001352952 us-gaap:ServiceMember 2023-04-01 2023-06-30 0001352952 us-gaap:ServiceMember 2023-01-01 2023-06-30 0001352952 us-gaap:ProductMember 2024-01-01 2024-06-30 0001352952 us-gaap:ProductMember 2024-04-01 2024-06-30 0001352952 us-gaap:ProductMember 2023-04-01 2023-06-30 0001352952 us-gaap:ProductMember 2023-01-01 2023-06-30 0001352952 us-gaap:ShippingAndHandlingMember 2024-01-01 2024-06-30 0001352952 us-gaap:ShippingAndHandlingMember 2024-04-01 2024-06-30 0001352952 us-gaap:ShippingAndHandlingMember 2023-04-01 2023-06-30 0001352952 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-06-30 0001352952 us-gaap:EmployeeStockOptionMember 2024-06-30 2024-06-30 0001352952 fil:Warrant1Member 2024-06-30 2024-06-30 0001352952 us-gaap:MachineryAndEquipmentMember 2024-06-30 0001352952 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001352952 us-gaap:FurnitureAndFixturesMember 2024-06-30 0001352952 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001352952 srt:RetailSiteMember 2024-06-30 0001352952 srt:RetailSiteMember 2023-12-31 0001352952 fil:PromissoryNotePayableMember 2019-09-10 2019-09-10 0001352952 fil:PromissoryNotePayableMember 2019-09-10 0001352952 fil:WarrantInConnectionWithPromissoryNoteMemberfil:PromissoryNotePayableMember 2019-09-10 0001352952 fil:PromissoryNotePayableMember 2024-06-30 0001352952 fil:CnpOperatingMember 2019-12-31 0001352952 fil:CnpOperatingMember 2024-06-30 0001352952 fil:CnpOperatingMember 2022-12-31 0001352952 fil:CnpOperatingMember 2019-10-28 0001352952 fil:CnpOperatingMember 2019-09-30 0001352952 fil:CnpOperatingMember 2019-09-30 2019-09-30 0001352952 fil:SbaMember 2020-06-24 2020-06-24 0001352952 2021-05-12 0001352952 fil:CSBGMemberfil:EagleOneMember 2021-05-12 0001352952 fil:CSBGMemberfil:EaglTwoMember 2021-05-12 0001352952 fil:PromissoryNotePayable6Member 2020-11-19 0001352952 fil:PromissoryNotePayable6Member 2020-11-19 2020-11-19 0001352952 fil:PromissoryNotePayable6Member 2024-01-01 2024-06-30 0001352952 fil:PromissoryNotePayable6Member 2024-06-30 0001352952 2021-10-19 0001352952 fil:PromissoryNotePayable9Member 2023-05-08 2023-05-08 0001352952 fil:PromissoryNotePayable10Member 2023-07-01 2023-07-01 0001352952 fil:RancoNotesMember 2024-01-01 2024-06-30 0001352952 fil:StockIssuance2Member 2023-01-01 2023-01-31 0001352952 fil:Warrant1Member 2023-12-31 0001352952 fil:Warrant1Member 2023-01-01 2023-12-31 0001352952 fil:Warrant1Member 2024-01-01 2024-06-30 0001352952 fil:Warrant1Member 2024-06-30 0001352952 fil:Warrant1Member 2024-04-01 2024-06-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

For the transition period from ________ to ________

Commission File Number: 000-52635

CFN ENTERPRISES INC.

(Exact name of registrant as specified in its charter)

Delaware	90-1559541
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

600 E. 8TH STREET

WHITEFISH, MT 59937

(Address of principal executive offices) (Zip code)

(833) 420-2636

(Registrant’s Telephone Number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares outstanding of the registrant’s Common Stock, $0.001 par value per share, as of August 12, 2024 was 82,210,664.

When used in this quarterly report, the terms “CFN Enterprises,” “the Company,” “we,” “our,” and “us” refer to CFN Enterprises Inc., a Delaware corporation, and its consolidated subsidiaries, unless the context indicates otherwise.

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION

This quarterly report on Form 10-Q contains certain forward-looking statements. Forward-looking statements may include our statements regarding our goals, beliefs, strategies, objectives, plans, including product and service developments, future financial conditions, results or projections or current expectations. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. For example, when we discuss our expectations for 2024, our expectations for revenue sources, costs of revenue and expenses going forward, and that we will continue to pursue strategic transactions and opportunities, we are using forward-looking statements. These statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause actual results to be materially different from those contemplated by the forward-looking statements. These factors include, but are not limited to, our ability to implement our strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. The business and operations of CFN Enterprises Inc. are subject to substantial risks, which increase the uncertainty inherent in the forward-looking statements contained in this report. Except as required by law, we undertake no obligation to release publicly the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Further information on potential factors that could affect our business is described under “Item 1A. Risk Factors” contained in our annual report on Form 10-K as filed with the Securities and Exchange Commission, or the SEC, on April 11, 2024. Readers are also urged to carefully review and consider the various disclosures we have made in this report and in our annual report on Form 10-K.

CFN ENTERPRISES INC.

INDEX

	Page

PART I - FINANCIAL INFORMATION:	1

Item 1. Financial Statements and accompanying Notes to the Financial Statements (Unaudited)	1

Item 2. Management’s Discussion and Analysis of Financial Position and Results of Operations	16

Item 4. Controls and Procedures	21

PART II - OTHER INFORMATION:	21

Item 6. Exhibits	21

SIGNATURES	21

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

CFN ENTERPRISES INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30,	December 31,
	2024	2023
	(Unaudited)
ASSETS
Current assets:
Cash	`$225,415`	`$78,744`
Restricted cash	`20,600`	`20,448`
Accounts receivable, net	`1,700,632`	`942,248`
Inventory	`1,864,703`	`1,796,227`
Total current assets	`3,811,350`	`2,837,667`
Property and equipment, net	`164,412`	`156,343`
Right of use asset	`1,860,574`	`2,159,043`
Deposits	`297,269`	`297,269`
Other assets	`8,810`	`8,910`
Total assets	`$6,142,415`	`$5,459,232`

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	`$4,440,176`	`$3,018,531`
Accrued liabilities	`5,529,570`	`3,828,063`
Due to related party	`501,140`	`501,140`
Deferred revenue	`235,125`	`484,212`
Current portion of notes payable	`7,362,408`	`7,272,357`
Due to seller	`1,000,000`	`1,000,000`
Contingent consideration	`208,000`	`208,000`
Current portion of right of use liability	`394,726`	`822,259`
Current liabilities of discontinued operations	`79,823`	`79,823`
Total current liabilities	`19,750,968`	`17,214,385`
Right of use liability	`1,584,214`	`1,547,410`
Long-term note payable, net of current portion and discounts	`126,981`	`128,443`
Total liabilities	`21,462,163`	`18,890,238`

Commitments and contingencies

Stockholders' deficit:

Series A preferred stock, $0.001 par value, 500 shares authorized, 500 shares issued and outstanding as of both June 30, 2024 and December 31, 2023	`1`	`1`
Series B preferred stock, $0.001 par value, 3,000 shares authorized, 3,000 shares issued and outstanding as of both June 30, 2024 and December 31, 2023	`3`	`3`
Common stock, $0.001 par value, 500,000,000 shares authorized, 82,210,664 shares issued and outstanding as of both June 30, 2024 and December 31, 2023	`82,210`	`82,210`
Additional paid-in capital	`61,039,808`	`60,909,641`
Accumulated deficit	`(76,441,770)`	`(74,422,861)`
Total stockholders' deficit	`(15,319,748)`	`(13,431,006)`
Total liabilities and stockholders' deficit	`$6,142,415`	`$5,459,232`

See accompanying notes to the unaudited condensed consolidated financial statements

CFN ENTERPRISES INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

	Three Months Ended June 30,		Six Months Ended June 30,
	2024	2023	2024	2023
Net revenues	`$5,893,962`	`$152,301`	`$9,738,554`	`$265,259`
Cost of revenue	`4,878,001`	`47,484`	`7,029,836`	`223,675`
Gross profit	`1,015,961`	`104,817`	`2,708,718`	`41,584`

Operating expenses:
Selling, general and administrative	`1,546,949`	`1,703,134`	`3,166,743`	`2,125,148`
Total operating expenses	`1,546,949`	`1,703,134`	`3,166,743`	`2,125,148`

Loss from operations	`(530,988)`	`(1,598,317)`	`(458,025)`	`(2,083,564)`

Other income (expense):
Interest expense	`(720,424)`	`(37,450)`	`(1,441,035)`	`(103,501)`
Gain on property and equipment	`-`	`9,253`	`-`	`9,253`
Gain on extinguishment of debt	`-`	`13,219`	`-`	`13,219`
Other income	`-`	`157,502`	`-`	`157,502`
Interest income	`74`	`81`	`151`	`157`
Total other income (expense), net	`(720,350)`	`142,605`	`(1,440,884)`	`76,630`

Provision for income taxes	`-`	`-`	`-`	`-`
Net loss	`$(1,251,338)`	`$(1,455,712)`	`$(1,898,909)`	`$(2,006,934)`
Preferred stock interest	`60,000`	`60,000`	`120,000`	`120,000`
Net loss available to common shareholders	`$(1,311,338)`	`$(1,515,712)`	`$(2,018,909)`	`$(2,126,934)`

Net loss per common share - basic and diluted	`$(0.02)`	`$(0.04)`	`$(0.02)`	`$(0.05)`

Weighted average common shares outstanding - basic and diluted	`82,210,664`	`40,846,664`	`82,210,664`	`40,255,331`

See accompanying notes to the unaudited condensed consolidated financial statements

CFN ENTERPRISES INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

Series A

Series B

Additional

Total

Preferred Stock

Common Stock

Paid-in

Accumulated

Stockholders'

Shares

Amount

Shares

Amount

Shares

Amount

Capital

Deficit

Balance at December 31,2022

500

$1

3,000

$3

37,690,664

$37,690

$49,786,056

$(58,996,099)

$(9,172,349)

Issuance of common stock for cash

-

2,400,000

2,400

597,600

-

600,000

Preferred stock interest

-

(60,000)

Net loss

-

(551,222)

Balances at March 31, 2023

500

1

3,000

3

40,090,664

40,090

50,383,656

(59,607,321)

(9,183,571)

Conversion of accrued preferred stock interest into shares

-

1,620,000

1,620

403,380

-

405,000

Stock compensation expense

-

1,156,100

-

1,156,100

Warrants issued with promissory notes

-

185,788

-

185,788

Preferred stock interest

-

(60,000)

Net loss

-

(1,455,712)

Balances at June 30, 2023

500

$1

3,000

$3

41,710,664

$41,710

52,128,924

$(61,123,033)

$(8,952,396)

Balance at December 31,2023

500

$1

3,000

$3

82,210,664

$82,210

$60,909,641

$(74,422,861)

$(13,431,006)

Contributed capital

-

71,000

-

71,000

Preferred stock interest

-

(60,000)

Net loss

-

(647,571)

Balances at March 31, 2024

500

1

3,000

3

82,210,664

82,210

60,980,641

(75,130,432)

(14,067,577)

Contributed capital

-

59,167

-

59,167

Preferred stock interest

-

(60,000)

Net loss

-

(1,251,338)

Balances at June 30, 2024

500

$1

3,000

$3

82,210,664

$82,210

61,039,808

$(76,441,770)

$(15,319,748)

See accompanying notes to the unaudited condensed consolidated financial statements

CFN ENTERPRISES INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	Six Months Ended June 30,
	2024	2023
Cash flows from operating activities:
Net loss	`$(1,898,909)`	`$(2,006,934)`
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	`17,910`	`5,663`
Amortization of right of use asset	`298,469`	`29,488`
Bad debt expense	`432,487`	`-`
Amortization of debt discount	`324,744`	`16,349`
Stock compensation expense	`-`	`1,156,100`
Gain on property and equipment	`-`	`(9,253)`
Gain on extinguishment of debt	`-`	`(13,219)`
Changes in operating assets and liabilities:
Accounts receivable, net	`(1,190,871)`	`(7,855)`
Inventory	`(68,476)`	`-`
Prepaid expenses and other assets	`100`	`(8,910)`
Accounts payable and accrued expenses	`3,003,152`	`351,937`
Deferred revenue	`(249,087)`	`5,349`
Payments made in advance of securities date	`-`	`32,500`
Right of use liability, net	`(390,729)`	`(115,493)`
Net cash provided by (used in) operating activities	`278,790`	`(564,277)`
Cash flows from investing activities:
Sale of assets held for sale	`-`	`608,300`
Purchase of property and equipment, net	`(25,979)`	`-`
Net cash (used in) provided by investing activities	`(25,979)`	`608,300`
Cash flows from financing activities:
Net advances from related parties	`-`	`(2,119)`
Proceeds from promissory notes	`-`	`1,175,000`
Repayments of notes	`(236,155)`	`(531,056)`
Contributed capital	`130,167`	`-`
Proceeds from sale of common stock	`-`	`350,000`
Net cash (used in) provided by financing activities	`(105,988)`	`991,825`
Net change in cash and cash equivalents	`146,823`	`1,035,848`
Cash and restricted cash at beginning of period	`99,192`	`32,602`
Cash and restricted cash at end of period	`$246,015`	`$1,068,450`

Reconciliation of cash and restricted cash:
Cash at beginning of period	`$78,744`	`$12,474`
Restricted cash at beginning of period	`20,448`	`20,128`
Cash and restricted cash at beginning of period	`$99,192`	`$32,602`

Cash at end of period	`$225,415`	`$1,048,166`
Restricted cash at end of period	`20,600`	`20,284`
Cash and restricted cash at end of period	`$246,015`	`$1,068,450`

Supplemental disclosure of cash flow information:
Cash paid for income taxes	`$-`	`$-`
Cash paid for interest	`$192,500`	`$-`

Supplemental disclosure of non-cash investing and financing activities:
Accrual of preferred stock interest	`$120,000`	`$120,000`
Warrants issued with promissory notes	`$-`	`$185,788`
Right of use asset and liability	`$-`	`$187,863`
Conversion of accrued preferred stock interest into shares	`$-`	`$405,000`

See accompanying notes to the unaudited condensed consolidated financial statements

CFN ENTERPRISES INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION

Organization

CFN Enterprises Inc., formerly known as Accelerize Inc., or the Company, is a Delaware corporation incorporated on November 22, 2005. Effective October 22, 2019, the Company filed a certificate of amendment to its certificate of incorporation with the Secretary of State of the State of Delaware to change its corporate name to CFN Enterprises Inc.

On May 15, 2019, the Company entered into an asset purchase agreement or the Emerging Growth Agreement with Emerging Growth, LLC, or Emerging Growth, pursuant to which the Company acquired certain assets from the Emerging Growth related to its sponsored content and marketing business for a purchase price consideration consisting of $420,000 in cash, 30,000,000 shares of the Company’s common stock, and 3,000 shares of Series B preferred stock with a total stated value of $3,000,000 which bears interest at 6% per annum and is convertible into the Company’s common stock at a conversion price to be mutually agreed in the future, without voting rights or a liquidation preference except with respect to default interest. The securities were issued pursuant to an exemption under Section 4(a)(2) of the Securities Act of 1933, as amended. The closing of the purchase of the assets pursuant to the Emerging Growth Agreement occurred on June 20, 2019.

On August 23, 2021, the Company entered into securities purchase agreements with CNP Operating, LLC, a Colorado limited liability company, or CNP Operating, and the owners of all of the equity interests of CNP Operating, or the Owners, whereby the Company acquired 100% of CNP Operating from the Owners in exchange for an aggregate of 23.6 million shares of the Company’s common stock. The securities were issued pursuant to an exemption under Section 4(a)(2) of the Securities Act of 1933, as amended. On August 25, 2021 the transaction was closed and CNP Operating became a wholly owned subsidiary of the Company. CNP Operating is a cannabidiol manufacturer. In the fourth quarter of 2022 and the first quarter of 2023, the Company took steps to wind down the operations of CNP Operating and focus on the CFN Business.

On December 6, 2021, the Company effected a reverse split of its outstanding common stock in the ratio of 1-for-15, or the Reverse Stock Split. All share amounts retrospectively reflect the effect of the Reverse Stock Split.

On July 1, 2023, the Company and its wholly owned subsidiary, Ranco LLC, a Delaware limited liability company, or Ranco, entered into an asset purchase agreement, or the Asset Purchase Agreement (“Ranco Agreement”) with RAN CoPacking Solutions LLC, a California limited liability company, or the Seller and the members of the Seller (collectively, the Founders). The assets of the Seller acquired by Ranco consist of assets for co-packing and white label manufacturing services, including comprehensive solutions for third party logistics (3PL) related areas such as storage, order fulfillment, solutions for custom packaging and hardware needs for many different industries, and media and design services, along with strategic marketing support, to help clients establish and enhance their brand presence in the market, or the Purchased Assets.

Also on July 1, 2023, Ranco entered into the Packwoods Private Label Services and Intellectual Property Licensing Agreement, or the Licensing Agreement, with PW Industries LLC, a Wyoming limited liability company, or PW, RS Distributions LLC, a Delaware limited liability company, or RS, and Packaging Innovations LLC, a Wyoming limited liability company, or PI, and together with PW and RS, the Licensors, for the exclusive manufacturing, packaging and distribution of, and wholesale and retail sales of a variety hemp-based inhalable (pre-roll and vaporizer), edible products, and disposable nicotine-based inhalable vaporizer products, and the purchase of packaging materials to be used with Packwoods-branded cannabis products (containing more than 0.3% delta-9 THC by weight) and the distribution of those packaging materials to licensed cannabis manufacturers designated by PW, using the Licensor’s licensed property for a 5 year exclusive term, subject to certain exclusions.

The Company’s current operations consist of the sponsored content and marketing business, or the CFN Business, from the assets acquired pursuant to the Emerging Growth Agreement, and the business of Ranco, or the Ranco Business.

Going Concern

The accompanying consolidated financial statements have been prepared on a going concern basis which implies the Company will continue to meet its obligations for the next 12 months as of the date these financial statements are issued.

The Company had a working capital deficit of $15,939,618 and an accumulated deficit of $76,441,770 as of June 30, 2024. The Company also had a net loss of $1,898,909 for the six months ended June 30, 2024.

Management’s plan to continue as a going concern includes raising capital in the form of debt or equity, growing the CFN Business, growing the newly acquired Ranco Business, managing and reducing operating and overhead costs and continuing to pursue strategic transactions and opportunities including launching an e-commerce network focused on the sale of general wellness cannabidiol, or CBD, products.

These matters, among others, raise substantial doubt about the ability of the Company to continue as a going concern. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

Basis of Presentation and Consolidation

The accompanying consolidated financial statements include the results of operations of the Company and its subsidiaries CNP Operating, a Delaware limited liability company, CNP of Wyoming, LLC, a Colorado limited liability company, and Ranco, LLC, a Delaware limited liability company. All intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation.

These unaudited condensed financial statements reflect all adjustments including normal recurring adjustments, which, in the opinion of management, are necessary to present fairly the financial position, results of operations, and cash flows for the periods presented in accordance with accounting principles generally accepted in the United States of America, or GAAP. These unaudited condensed consolidated financial statements and notes included herein should be read in conjunction with the Company’s consolidated financial statements and notes thereto for the years ended December 31, 2023 and 2022, which are included in the Company’s December 31, 2023 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission on April 11, 2024. The Company assumes that the users of the interim financial information herein have read, or have access to, the audited consolidated financial statements for the preceding period, and that the adequacy of additional disclosure needed for a fair presentation of these may be determined in that context. The results of operations for the period ended June 30, 2024 are not necessarily indicative of results for the entire year ending December 31, 2024.

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, borrowing rate considered for operating lease right-of-use asset and related operating lease liability, and assumptions used in Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

Segment Reporting

The Company operates under one reporting segment.

Cash and Cash Equivalents

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less when purchased, to be cash equivalents. The Company has restricted cash as a result of its corporate card program through its bank, which requires collateral placed in a money market account. At June 30, 2024, the Company had a restricted cash balance of $20,600 included as a component of total cash and restricted cash as presented on the accompanying unaudited condensed consolidated statement of cash flows.

Accounts Receivable

The Company’s account receivables for the CFN Business are due from customers relating to contracts to provide investor relation services for the CFN Business. For the Ranco Business, accounts receivables are due from customers for products sold and manufacturing, packing and labeling services provided. Collateral is currently not required. The Company also maintains allowances for doubtful accounts for estimated losses resulting from the inability of the Company’s customers to make payments. The Company periodically reviews these estimated allowances, including an analysis of the customers’ payment history and creditworthiness, the age of the trade receivable balances and current economic conditions that may affect a customer’s ability to make payments as well as historical collection trends for its customers as a whole. Based on this review, the Company specifically reserves for those accounts deemed uncollectible or likely to become uncollectible. When receivables are determined to be uncollectible, principal amounts of such receivables outstanding are deducted from the allowance. The allowance for doubtful accounts as of June 30, 2024 and December 31, 2023 amounted to $754,726 and $796,251, respectively.

Inventory

The Company’s inventory consists of finished goods acquired for its Ranco business. As of June 30, 2024, all inventory consisted of disposable nicotine-based inhalable vaporizer products purchased from overseas. The inventory is valued at the lower of cost (specific identification) or estimated net realizable value. As of June 30, 2024, the Company valued the inventory at $1,864,703.

Concentration of Credit Risks

The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.

The Company’s cash and restricted cash accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. From time-to-time, the Company’s bank balances exceed the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.

Concentrations

The Company had two customers which accounted for 39% of accounts receivable as of June 30, 2024. During the three and six months ended June 30, 2024, one customer accounted for 52% and 33% of the Company’s revenues, respectively. The Company may be negatively affected by the loss of one of these customers.

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification, or ASC, 606, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.

The Company accounts for revenues when both parties to the contract have approved the contract, the rights and obligations of the parties are identified, payment terms are identified, and collectability of consideration is probable. Payment terms vary by client and the services offered.

CFN Business

Subsequent to the closing of the Emerging Growth Agreement on June 20, 2019, the Company’s revenue is generated from the sale of promotional service packages to its customers ranging from 3 to 6 months. The Company offers different packages tailored to the type and stage of the potential customer, such as public companies looking to increase their shareholder base, as well as private companies potentially looking to go public and attract capital and publicity. The services provided by the Company include advertising, publishing of interviews and articles across its network and featuring of client content on its newsletters and social media. The packages all have fixed prices that are billed monthly over the terms of the agreement in even amounts. The Company recognizes revenue for its performance obligation associated with its contracts with customers over time as work is performed, which is deemed to occur evenly throughout the duration of the contract. This also reflects the pattern in which costs are incurred on performing the contracts. To the extent revenue recognized on contracts at each period end exceeds collections, the amounts are reflected as accounts receivable. To the extent collections on contracts at each period end exceeds revenue recognized, the amounts are reflected as deferred revenue.

Ranco Business

The Company performs services including white label manufacturing and co-packing for customers. Customers will drop off their product and the Company will perform the services via their employees and contractors. When the services are complete, the Company has satisfied its performance obligations. Revenue is recognized at this point in time.

The Company will order products that are manufactured overseas, such as custom boxes, packaging and hardware. These products are generally shipped from overseas to the customer. When these products are shipped out from the manufacturer, the Company has satisfied its performance obligations. Revenue is recognized at this point in time.

Lastly, the Company provides certain shipping and third party logistics services for customers. Once the products have arrived from overseas to the Company’s warehouse, the Company has satisfied its performance obligations which was the underlying shipping and logistics services. Revenue is recognized at this point in time.

Disaggregation of Revenue

The following is a disaggregation of revenue for the six months and three months ended June 30, 2024 and 2023 respectively:

	Three Months Ended June 30,		Six Months Ended June 30,
	2024	2023	2024	2023
Services (CFN and Ranco services)	`$933,744`	`$152,301`	`$3,089,647`	`$265,259`
Products	`4,548,621`	`-`	`6,050,224`	`-`
Shipping and logistics	`411,597`	`-`	`598,683`	`-`
	`$5,893,962`	`$152,301`	`$9,738,554`	`$265,259`

Contract Liabilities

In some instances, customers provide payment before the Company has satisfied its performance obligations. These amounts are recorded to deferred revenue. As of June 30, 2024 and December 31, 2023, the Company had $235,125 and $484,212, respectively in deferred revenue.

Cost of Revenue

Cost of revenue includes direct labor and materials. Cost of revenues also includes inbound and outbound shipping, freight and delivery costs.

Shipping and Handling Fees and Costs

Amounts billed to customers for shipping and handling fees are presented in revenue. Costs incurred for shipping and handling are included in cost of revenue.

Fair Value of Financial Instruments

The Company accounts for assets and liabilities measured at fair value on a recurring basis in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, or ASC 820. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value, and expands disclosure about such fair value measurements.

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:

Level 1:	Observable inputs such as quoted market prices in active markets for identical assets or liabilities.

Level 2:	Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3:	Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

The carrying value of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, deferred revenue and due to related party approximate their fair value due to the short-term maturity of these items. The Company’s notes payable approximate their fair value due to the market rate of interest on the notes.

The Company’s contingent consideration recorded in connection with the Ranco acquisition (see Note 3) is a Level 3 liability. The liability is valued using a probability weighted analysis of the respective earn out provisions.

Business Combinations

The Company accounts for acquisitions in which it obtains control of one or more businesses as a business combination. The purchase price of the acquired businesses is allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the purchase price over those fair values is recognized as goodwill. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments, in the period in which they are determined, to the assets acquired and liabilities assumed with the corresponding offset to goodwill. If the assets acquired are not a business, the Company accounts for the transaction or other event as an asset acquisition. Under both methods, the Company

recognizes the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquired entity. In addition, for transactions that are business combinations, the Company evaluates the existence of goodwill or a gain from a bargain purchase.

Goodwill represents the excess of the purchase price of an acquired entity over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed in a business combination.

Impairment

Long-Lived Assets

In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made.

Contingent Consideration

The Company records a contingent consideration liability relating to earn the Company’s shares included in its acquisition agreements. The estimated fair value of the contingent consideration is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument.

The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets.

Ranco Earnout

The Ranco Agreement contains an earn out provision providing for the issuance of (i) 8 million shares of Company common stock to be issued upon Ranco achieving $19 million in gross revenue attributable to the Purchased Assets and a net profit of $3.9 million within the twelve month period beginning three months from the closing of the Acquisition, or the First Earnout Period, and (ii) 8 million shares of Company common stock to be issued upon Ranco achieving $29 million in gross revenue attributable to the Purchased Assets and a net profit of $5.9 million within the twelve month period beginning on the day immediately following the end of the First Earnout Period.

The Company utilized a probability weighted scenario based on the earnout provisions above and determined the fair value of the contingent consideration was $208,000, which is a Level 3 financial instrument. There was no change to the fair value for the contingent consideration as of June 30, 2024.

Advertising

The Company expenses advertising costs as incurred. Advertising expenses for the three months ended June 30, 2024 and 2023 amounted to $65,383 and $15,355, respectively. Advertising expenses for the six months ended June 30, 2024 and 2023 amounted to $84,709 and $27,969, respectively.

Property and Equipment

Property and equipment are recorded at cost and are depreciated on a straight-line basis over their estimated useful lives of five years. Maintenance and repairs are charged to expense as incurred. Significant renewals and betterments are capitalized.

Basic and Diluted Earnings Per Share

Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period. Dilutive common share equivalents consist of shares issuable upon the exercise

of stock options and warrants (calculated using the modified-treasury stock method). As of June 30, 2024, the Company had no outstanding stock options, 11,988,500 outstanding warrants and 3,500 shares of preferred stock which were excluded from the calculation of diluted earnings per share because their effects were anti-dilutive. As of June 30, 2023, the Company had no outstanding stock options, 8,138,500 outstanding warrants and 3,500 shares of preferred stock which were excluded from the calculation of diluted earnings per share because their effects were anti-dilutive. As a result, the basic and diluted earnings per share are the same for each of the periods presented.

Share-Based Payments

The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation-Stock Compensation, or ASC 718. Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.

The Company has elected to use the Black-Scholes option-pricing model to estimate the fair value of its options, which incorporates various subjective assumptions including volatility, risk-free interest rate, expected life, and dividend yield to calculate the fair value of stock option awards. Compensation expense recognized in the statements of operations is based on awards ultimately expected to vest and reflects estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

Leases

The Company adopted Accounting Standards Update No. 2016-02, Leases (“Topic 842”) using the modified retrospective method. This accounting standard requires a lessee to recognize an asset and liability for most leases on its balance sheet.

Under Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement and leases with an initial term of 12 months or less are not included in lease liabilities or ROU asset. As most leases do not provide an implicit rate, a rate which approximates the Company’s incremental borrowing rate is used, based on the information available at commencement date, in determining the present value of lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred. Lease agreements generally do not contain residual value guarantees or restrictive covenants. Over the lease term, the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized in a manner that results in straight-line expense recognition.

NOTE 3: BUSINESS COMBINATIONS

RAN CoPacking Solutions LLC

The Company evaluated the Asset Purchase Agreement pursuant to ASC 805 and ASU 2017-01, Topic 805, Business Combinations. The Company first determined that the Seller met the definition of a business as it includes inputs and a substantive process that together significantly contribute to the ability to create outputs. The Seller’s results of operations are included in the Company’s consolidated financial statements from the date of acquisition.The acquisition method of accounting requires, among other things, that the assets acquired and liabilities assumed in a business combination be measured at their estimated respective fair values as of the closing date of the acquisition. Goodwill recognized in connection with this transaction represents primarily the potential economic benefits that the Company believes may arise from the acquisition The purchase price allocation is preliminary and could be significantly revised as a result of additional information obtained regarding assets acquired and liabilities assumed and revisions of estimates of fair values of tangible assets and related deferred tax assets and liabilities. The Company will finalize its valuation and the allocation of the purchase price, along with required retrospective adjustments, if any, within a year following the acquisition date.

Total fair value of the preliminary purchase price consideration as of July 1, 2023 was determined as follows:

Cash (due to seller)		`$1,000,000`
Common stock		`8,000,000`
Contingent consideration		`208,000`
Purchase price consideration		`$9,208,000`

On July 1, 2023, the Company issued 40,000,000 shares of common stock pursuant to the Asset Purchase Agreement for a fair value of $8,000,000, or $0.20 per share.

Pursuant to the Asset Purchase Agreement, the Company owes the Seller $1,000,000 in cash consideration. The amount was recorded as a due to seller liability on the consolidated balance sheet. As of June 30, 2024, no payments were made.

In accordance with the Earn Out provisions per the Asset Purchase Agreement, the Company determined an initial fair value of $208,000 based on the fair value of the shares at the acquisition date and probabilities of the respective Earn Out terms. There was no change in fair value of the contingent consideration at June 30, 2024.

Preliminary Purchase Price Allocation

The Company has made a preliminary allocation of the purchase price in regard to the acquisition related to the assets acquired and the liabilities assumed as of the purchase date. The following table summarizes the preliminary purchase price allocation:

Cash		`$134,060`
Accounts receivable		`175,340`
Deposits		`297,269`
Goodwill		`8,676,430`
Right of use asset		`2,272,059`
Accounts payable		`(48,430)`
Current portion of right of use liability		`(538,243)`
Right of use of liability		`(1,760,485)`
Purchase price consideration		`$9,208,000`

Goodwill is primarily attributable to the go-to-market synergies that are expected to arise as a result of the acquisition and other intangible assets that do not qualify for separate recognition. The goodwill is not deductible for tax purposes.

Unaudited Pro Forma Financial Information

The following unaudited pro forma financial information presents the Company’s financial results as if the RAN CoPacking Solutions LLC acquisition had occurred as of January 1, 2023. The unaudited pro forma financial information is not necessarily indicative of what the financial results actually would have been had the acquisitions been completed on this date. In addition, the unaudited pro forma financial information is not indicative of, nor does it purport to project, the Company’s future financial results. The unaudited pro forma information does not give effect to any estimated and potential cost savings or other operating efficiencies that could result from the acquisition:

		Six Months
		Ended
		June 30,
		2023
Net revenues		`$2,459,000`
Net loss		`$(2,282,313)`
Net loss per common share		`$(0.06)`

NOTE 4: PROPERTY AND EQUIPMENT

The Company’s property and equipment relating to continuing operations consisted of the following:

	June 30,	December 31,
	2024	2023
Machinery & equipment	`$69,270`	`$50,000`
Furniture and equipment and leasehold improvements	`14,773`	`14,773`
Tradeshow booth	`168,909`	`162,200`
	`252,952`	`226,973`
Less: Accumulated depreciation	`(88,540)`	`(70,630)`
	`$164,412`	`$156,343`

Depreciation expense for the three months ended June 30, 2024 and 2023 amounted to $9,478 and $2,831, respectively. Depreciation expense for the six months ended June 30, 2024 and 2023 amounted to $17,910 and $5,664, respectively.

NOTE 5: NOTES PAYABLE

On September 10, 2019, the Company entered into a promissory note payable whereby the Company borrowed $500,000 bearing interest at 8% per annum. Interest on the note is payable quarterly on the first business day of December, March, June and September commencing December 1, 2019. In May 2021, the Company and the holder of the promissory note reached an agreement to extend the maturity date of the note from September 30, 2022 to September 30, 2024. In connection with the extension, the Company issued 160,000 shares of its common stock to the noteholder in lieu of $40,000 of interest accrued and accruing on the promissory note through December 31, 2022. In 2022, the maturity date was extended to 2024.

In connection with the promissory note on September 10, 2019, the Company issued warrants to purchase 33,333 shares of the Company’s common stock at an exercise price of $1.50 per share. The warrants were exercised on June 30, 2021 and the Company received $50,000. The note was discounted by $17,624 allocated from the valuation of the warrants issued. The discount recorded on the note is being amortized as interest expense through the maturity date. As of June 30, 2024, the net book value of the promissory note amounted to $500,000, including the principal amount of $50,000 which was fully amortized.

On October 28, 2019, the Company’s subsidiary CNP Operating entered into a promissory note payable with Complete Business Solutions Group, Inc (“CBSG”) whereby the Company borrowed $3,050,000. The outstanding balance of the note was $2,218,000 at December 31, 2022. At December 31, 2022, the Company reversed $1,312,080 previously recorded to additional paid-in capital in 2022 to reflect the outstanding principal of $2,218,000. The note is currently in default and personally guaranteed by Anthony Zingarelli.

On September 30, 2019, the Company’s subsidiary CNP Operating entered into a promissory note payable with Eagle Six Consultants, Inc. (“Eagle”) whereby the Company borrowed $550,000 bearing interest at 16% per annum. The outstanding balance of the note was $302,489 at June 30, 2024. The note is currently in default.

On June 24, 2020, the Company entered into a Loan Authorization and Agreement with the SBA under which the Company borrowed $150,000 and issued to the SBA a note and security agreement for the amount borrowed. Outstanding borrowings accrue interest at a rate of 3.75% per annum, and installment payments, including principal and interest, of $731 are due monthly and begin 12 months from the date of the loan agreement. The balance of any remaining principal and interest is due 30 years from the date of the loan agreement. As collateral for the borrowing, the Company granted the SBA a security interest in substantially all assets of the Company.

On May 12, 2021, the Company’s subsidiary CNP Operating restructured the CSBG note payable of $2,957,000, the Eagle #1 note payable of $550,000 and the Eagle #2 note payable of $300,000 by entering into a payment and indemnification agreement with the receivers/trustee of CBSG and Eagle. The receiver has agreed that the balance of the outstanding amounts will be paid over the course of 24 months in equal payments of $158,625. Further, the Company shall pay $20,000 per month toward the balance and Anthony Zingarelli (“Zingarelli”) and Colorado Sky Industrial Supply LLC (“CSIS”), agree to personally pay the sum of $138,625 per month. Zingarelli is the only member of CNP Operating that signed a personal guarantee on the loans and Zingarelli is the sole member of CSIS. Zingarelli and CSIS has agreed to indemnify and hold the Company harmless from any and all losses, liabilities and claims. If a loss is incurred by the Company with respect to any claims, Zingarelli shall reimburse the Company for the amount of any such loss. The Company has recorded the Zingarelli payments during the period as contributions to additional paid in capital through December 31, 2021. This note is currently in default.

On November 19, 2020, the Company’s subsidiary CNP Operating purchased equipment for $58,095 which was financed at zero interest rate. The monthly payments of $968 will be made for the next 60 months and mature on November 19, 2025. Imputed interest was not material. The outstanding balance of the note was $34,892 at December 31, 2022. In 2022, CNP Operating purchased equipment for $55,016 which was financed at zero interest rate with the same lender with similar terms. The outstanding balance of the note was $48,513 at June 30, 2024.

On October 19, 2021, the Company borrowed $250,000 from a lender and issued a promissory note for the repayment of the amount borrowed. The promissory note is unsecured, has a maturity date of December 31, 2024 and all principal is due upon maturity. The amount borrowed accrues interest at 12% per annum and accrued interest is payable monthly commencing on December 1, 2021. The promissory note contains customary events of default permitting acceleration of repayment for nonpayment of amounts due, a bankruptcy related proceeding, breach of representations or covenants, sale of substantially all assets, and change of control.

On May 8, 2023, the Company entered into a promissory note with two lenders for aggregate proceeds of $1,150,000. The notes are unsecured and have a maturity date 15 months following their issuance. Beginning on the fourth month after issuance, the Company will make monthly repayments totaling $143,750, including principal and interest. Total principal and interest to be repaid is $1,725,000, and any remaining outstanding balance is due at maturity. In connection with the notes, the Company granted an aggregate of 1,150,000 warrants to the lenders with an exercise price of $0.25 per share. The fair value of the warrants was $185,788, which was recognized as a debt discount and will be amortized to interest expense over the life of the notes. During the six months ended June 30, 2024, amortization of debt discount was $74,316. As of June 30, 2024, note payable, net of unamortized discount of $20,808, was $695,442 for these two notes.

On July 1, 2023, the Company entered into a promissory note with two lenders for aggregate proceeds of $3,850,000. The notes are unsecured and have a maturity date 15 months following their issuance. In connection with the notes, the Company granted an aggregate of 3,850,000 warrants to the lenders with an exercise price of $0.25 per share. The fair value of the warrants was $626,073, which was recognized as a debt discount and will be amortized to interest expense over the life of the notes. During the six months ended June 30, 2024, amortization of debt discount was $250,430. As of June 30, 2024, note payable, net of unamortized discount of $125,214, was $3,275,618 for these two notes.

On July 1, 2023, the May and July notes were rolled over to Ranco, LLC for an aggregate of $5,000,000 (the “Ranco Notes”). The Ranco Notes have a 15 month term and are subject to mandatory equal repayments commencing on the fourth month following issuance, for an aggregate repayment of $7,500,000. The Ranco Notes are secured by the assets of Ranco and guaranteed by the Company.

Future scheduled maturities of long-term debt are as follows:

		June 30, 2024
2024		`7,362,408`
2025		`8,772`
2026		`8,772`
2027		`8,772`
Thereafter		`100,665`
		`7,489,389`

The aggregate current portion of long-term debt as of June 30, 2024 amounted is $7,362,408, which represents the contractual principal payments due in the next 12 months period as well as any notes in default.

NOTE 6: STOCKHOLDERS’ DEFICIT

Common Stock

In January 2023, the Company issued 2,400,000 shares of common stock at a purchase price of $0.25 per share for $600,000 in gross proceeds.

Preferred Stock

The Company is authorized to issue 2,000,000 shares of preferred stock with a par value of $0.001 per share, of which 500 have been authorized as Series A Preferred Stock and 3,000 have been authorized as Series B Preferred Stock.

For the six months ending June 30, 2024 and 2023, the Company incurred $120,000 and $120,000, respectively, of interest from the outstanding preferred stock.

Warrants

The following summarizes the Company’s warrant activity for the six months ended June 30, 2024:

			Weighted-Average
		Weighted-	Remaining
		Average	Contractual Life
	Warrants	Exercise Price	(Years)
Outstanding at December 31, 2023	`11,988,500`	`$0.41`	`4.18`
Granted	`-`	`-`	`-`
Forfeited	`-`	`-`	`-`
Outstanding at June 30, 2024	`11,988,500`	`$0.41`	`3.68`


Vested and expected to vest at June 30, 2024	`11,988,500`	`$0.41`	`3.68`
Exercisable at June 30, 2024	`11,988,500`	`$0.41`	`3.68`

As of June 30, 2024, all outstanding warrants were fully vested and there was no remaining unrecorded compensation expense.

Options

The Company had a Stock Option Plan, or the Plan, under which the total number of shares of capital stock of the Company that may be subject to options under the Plan was 1,500,000 shares of Common Stock from either authorized but unissued shares or treasury shares. The Plan expired on December 14, 2016.

As of June 30, 2024, there were no outstanding options.

NOTE 7: LEASES

On April 1, 2023, Emerging Growth LLC entered into a modification of the existing lease agreement for its premises in Whitefish, Montana commencing April 11, 2023, for a period of five years at a rate of $3,750 per month, which lease contains an option for the Company to renew the lease for a period of one additional year at a monthly rent subject to a 3% increase. In connection with this lease, the Company recorded a ROU asset and liability of $187,863.

In connection with the Ranco acquisition, the Company agreed to assume the Seller’s lease for property related to the Purchased Assets in Los Angeles, California, consisting of approximately 46,000 square feet of space. The Ranco operating lease agreement commenced on July 1, 2022 and expires on July 31, 2027. The lease requires monthly base rent payments of $49,782 and required a security deposit of $297,269. Upon the Ranco acquisition, the Company recognized a right of use asset of $2,270,059 and right of use liability of $1,760,485. Furthermore, the Company acquired the existing security deposit of $297,269. In 2023, the Company recognized a right of use asset of $1,993,847 and right of use liability of $2,031,541.

The following is a summary of related liabilities for all non-cancelable operating leases:

	June 30,	December 31,
	2024	2023
Operating leases
Assets
Right of use asset	`$1,860,574`	`$2,159,043`

Liabilities
Current portion of right of use liability	`$394,726`	`$822,259`
Right of use liability	`1,584,214`	`1,547,410`
Total operating lease liabilities	`$1,978,940`	`$2,369,669`

Weighted average remaining lease term (years)	`2.56`	`3.06`
Weighted average discount rate	`10.00%`	`10.00%`

NOTE 8: RELATED PARTY TRANSACTIONS

As of June 30, 2024 and December 31, 2023, there was $501,140 and $501,140, respectively, in amounts due to related parties, including $428,700 due to CSIS. The advances are unsecured, non-interest bearing and due on demand.

During the six months ended June 30, 2024, the executives of Ranco paid payroll to certain employees totalling $130,167. The payroll was for Ranco employees, and as such, the Company recorded the expense accordingly. The amounts were paid by the executives themselves and were recognized as contributed capital into the Company. The amounts are not liable by the Company (Ranco LLC and CFN Enterprises, Inc.) for repayment.

NOTE 9: COMMITMENTS AND CONTINGENCIES

Legal Proceedings

From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. Except as set forth below, the Company is not presently a party to any legal proceedings that it currently believes, if determined adversely to the Company, would individually or taken together have a material adverse effect on the Company’s business, operating results, financial condition or cash flows.

In October 2022, CAKE Software Inc., or CAKE, filed a lawsuit against the Company in the Supreme Court of the State of New York, County of New York, captioned CAKE Software, Inc. v. Accelerize Inc. n/k/a CFN Enterprises Inc., Index No. 653838/2022. On December 6, 2022, CAKE filed an amended complaint, which is the operative complaint in this matter. CAKE's lawsuit stems from an Asset Purchase Agreement, or the APA, executed by the parties in May 2019, in which CAKE was the buyer of certain assets from the Company. CAKE alleges that the Company breached the APA by not paying a purported outstanding amount due which was to be calculated post-closing, and for breaching certain representations and warranties in the APA. CAKE further seeks indemnification under the APA for what it alleges are liabilities the Company retained after the closing of the sale. Based on its claims, CAKE is seeking compensatory damages of at least $1,045,441.86, attorney's fees, interests and costs, and such other relief as the court may deem just and appropriate.

In January 2023, the Company filed its initial Answer and Counterclaims, denying the material allegations and asserting its own claims against CAKE and Perseus Operating Group, or Perseus, a division of Constellation Software Inc. (TSX:CSU, OTCPK: CNSWF; www.csisoftware.com), or Constellation Software. On July 19, 2023, the parties held a mediation but were unsuccessful in reaching an agreement.

On September 25, 2023, after prevailing on a motion for leave to amend its initial Answer with Counterclaims, the Company filed its Amended Answer with Counterclaims against CAKE and Constellation Software itself, instead of its operating group, Perseus. The Amended Answer with Counterclaims is the Company’s operative pleading in this matter, and through it, the Company asserts that CAKE breached the APA by failing to pay the Company an earn-out, calculated in accordance with the APA, over a three-year period and totaling no less than $12,375,000, and that CAKE failed to pay the Company a $500,000 holdback amount. The Company further alleges that Constellation Software is the alter ego of CAKE, and therefore, is also liable under the APA. Through its amended counterclaims, the Company seeks compensatory damages of no less than $12,875,000, encompassing the earn-out amounts owed and the holdback amount, plus attorneys' fees, interests and costs, and other such relief as the court may deem just and proper.

On November 3, 2023, CAKE and Constellation Software filed replies to the Company’s amended counterclaims. Currently, the parties are engaged in the discovery process and a status conference with the Court regarding discovery is scheduled for December 8, 2024. The Company expects to vigorously defend against CAKE and Constellation Software’s claims, and to pursue its own counterclaims against CAKE, Constellation Software, and any other persons that it may identify through discovery to have harmed the Company or to have taken any action to interfere with the Company’s ability to receive its earn-out and/or the holdback amount.

The Company has determined that potential losses in this matter are neither probable or reasonably possible at this time.

NOTE 10: SUBSEQUENT EVENTS

On June 17, 2024, the Company commenced a written consent solicitation from its stockholders to approve an amendment to the Company’s Certificate of Incorporation, as amended, to effect a reverse split of the Company’s Common Stock (, in the range from 1-for-2 to 1-for-50, with the exact ratio to be determined in the sole discretion of the Company’s Board of Directors (the “Board”) no later than one year after approval (the “Amendment”), and the first consent was mailed on June 21, 2024. As of July 5, 2024, the Company’s stockholders had approved the Amendment and the Company ended the written consent solicitation. The Amendment required the written consent of the majority of the Company’s issued and outstanding shares of Common Stock. At the record date for the written consent solicitation the Company had 82,210,664 shares of Common Stock issued and outstanding. The votes as of July 5, 2024 were as follows, with holders of 60.98% of the Company’s issued and outstanding shares of Common Stock approving the Amendment:

For		Against		Abstain		Broker Non-Votes
50,128,962		-		-		-

If the Board determines to implement the Amendment, the Company will communicate to the public, prior to the effective time of the Amendment, additional details regarding the Amendment (including the final reverse split ratio, as determined by the Board). The Board reserves the right to elect not to proceed with implementing the Amendment if it determines, in its sole discretion, that the Amendment is no longer in the best interests of the Company or its stockholders.

Management has evaluated subsequent events through August 12, 2024, the date the consolidated financial statements were available to be issued. Based on this evaluation, no additional material events were identified which require adjustment or disclosure in these financial statements.

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and related notes included elsewhere in this report and our Annual Report on Form 10-K for the year ended December 31, 2023. Certain statements in this discussion and elsewhere in this report constitute forward-looking statements. See “Cautionary Statement Regarding Forward Looking Information’’ elsewhere in this report. Because this discussion involves risk and uncertainties, our actual results may differ materially from those anticipated in these forward-looking statements.

Overview

We own and operate a cannabis industry focused sponsored content and marketing business, or the CFN Business, and a white label manufacturing and co-packing business, or the Ranco Business. Our ongoing operations currently consist primarily of the CFN Business and the Ranco Business and we will continue to pursue strategic transactions and opportunities. We are currently in the process of launching an e-commerce network focused on the sale of general wellness CBD products. We also own CNP Operating which is a cannabidiol manufacturer. In the fourth quarter of 2022 and the first quarter of 2023, the Company took steps to wind down the operations of CNP Operating and focus on the CFN Business and the Ranco Business.

On July 1, 2023, the Company, through its wholly owned subsidiary, RANCO, LLC, a Delaware limited liability company, or Ranco, acquired assets from RAN CoPacking Solutions LLC, a California limited liability company, or the Acquisition which consists of assets for co-packing and white label manufacturing services, including comprehensive solutions for third party logistics (3PL) related areas such as storage, order fulfillment, solutions for custom packaging and hardware needs for many different industries, and media and design services, along with strategic marketing support, to help clients establish and enhance their brand presence in the market. Also on July 1, 2023, Ranco entered into the Packwoods Private Label Services and Intellectual Property Licensing Agreement, or the Licensing Agreement, with PW Industries LLC, a Wyoming limited liability company, or PW, RS Distributions LLC, a Delaware limited liability company, or RS, and Packaging Innovations LLC, a Wyoming limited liability company, or PI, and together with PW and RS, the Licensors, for the exclusive manufacturing, packaging and distribution of, and wholesale and retail sales of a variety hemp-based inhalable (pre-roll and vaporizer), edible products, and disposable nicotine-based inhalable vaporizer products, and the purchase of packaging materials to be used with Packwoods-branded cannabis products (containing more than 0.3% delta-9 THC by weight) and the distribution of those packaging materials to licensed cannabis manufacturers designated by PW, using the Licensor’s licensed property for a 5 year exclusive term, subject to certain exclusions.

The CFN Business generates revenue through sponsored content, including articles, press releases, videos, podcasts, advertisements and other media, email advertisements and other marketing campaigns run on behalf of public and private companies in the cannabis industry, helping them reach accredited, retail and institutional investors. Most revenue is generated through contracts involving a monthly cash payment.

Ranco performs services including white label manufacturing and co-packing for customers. Customers will drop off their product and the Company will perform the services via their employees and contractors. Ranco will also order products that are manufactured overseas, such as custom boxes, packaging and hardware. These products are generally shipped from overseas to the customer. Lastly, Ranco provides certain shipping and third party logistics services for customers.

Results of Operations for the Three Months Ended June 30, 2024 and 2023

The following are the results of our operations for the three months ended June 30, 2024 as compared to the three months ended March 31, 2023:

	Three Months Ended June 30,
	2024	2023	Change
Net revenues	`$5,893,962`	`$152,301`	`$5,741,661`
Cost of revenue	`4,878,001`	`47,484`	`4,830,517`
Gross profit	`1,015,961`	`104,817`	`911,144`

Operating expenses:
Selling, general and administrative	`1,546,949`	`1,703,134`	`(156,185)`
Total operating expenses	`1,546,949`	`1,703,134`	`(156,185)`

Loss from operations	`(530,988)`	`(1,598,317)`	`1,067,329`

Other income (expense):
Interest expense	`(720,424)`	`(37,450)`	`(682,974)`
Gain on property and equipment	`-`	`9,253`	`-`
Gain on extinguishment of debt	`-`	`13,219`	`-`
Other income	`-`	`157,502`	`-`
Interest income	`74`	`81`	`(7)`
Total other income (expense), net	`(720,350)`	`142,605`	`(682,981)`

Provision for income taxes	`-`	`-`	`-`
Net loss	`$(1,251,338)`	`$(1,455,712)`	`$384,348`

Net Revenues

The Company’s revenues from the CFN Business are generated from the sale of promotional service packages to customers ranging from 3 to 6 months. The Company offers different packages tailored to the type and stage of the potential customer, such as public companies looking to increase their shareholder base, as well as private companies potentially looking to go public and attract capital and publicity. Ranco performs services including white label manufacturing and co-packing for customers. Customers will drop off their product and the Company will perform the services via their employees and contractors. When the services are complete, the Company has satisfied its performance obligations. Revenue is recognized at this point in time. Ranco will order products that are manufactured overseas, such as custom boxes, packaging and hardware. These products are generally shipped from overseas to the customer. When these products are shipped out from the manufacturer, the Company has satisfied its performance obligations. Revenue is recognized at this point in time. Lastly, Ranco provides certain shipping and third party logistics services for customers. When the services are complete, the Company has satisfied its performance obligations. Revenue is recognized at this point in time.

Revenues increased by $5,741,661 to $5,893,962 for the three months ended June 30, 2024, compared to $152,301 in the corresponding fiscal period in 2023. The increase was primarily due to the acquisition of Ranco in July 2023.

During the three months ended June 30, 2024, the Company realized $0 of campaign revenue compared to $132,040 in the corresponding period in 2023. The decrease was primarily due to a shift in efforts during the period to the Ranco Business.

Our revenue for the period June 30, 2024 and 2023 also included $5,984 and $20,237 respectively, relating to sales of product from our e-commerce network focused on the sale of general wellness CBD products.

During the three months ended June 30, 2024, CNP Operating was no longer operating nor generating revenue.

During the three months ended June 30, 2024, the Company’s Ranco subsidiary generated revenue of $9.6 million.

Cost of Revenue

The costs of revenue for the CFN Business consist primarily of labor, fees paid for production of content for clients and the costs of placement of the content on various platforms. Cost of revenue also includes products sold, shipping costs and direct labor in the Ranco Business.

Cost of revenue increased by $4,830,517 to $4,878,001 for the three months ended June 30, 2024, compared to $47,484 in the corresponding fiscal period in 2023. The increase was primarily due to the Ranco business acquired in July 2023.

Operating Expenses

The Company’s operating expenses for the three months ended June 30, 2024 were lower than those in the corresponding period in 2023 due to the acquisition of Ranco in July 2023, including higher payroll, professional fees and travel.

Other Income/Expense

Other income/expenses during the three months ended June 30, 2024 were due to interest expense related to notes payable, which includes amortization of debt discount on Ranco’s notes.

Results of Operations for the Six Months Ended June 30, 2024 and 2023

The following are the results of our operations for the six months ended June 30, 2024 as compared to the six months ended June 30, 2023:

	Six Months Ended June 30,
	2024	2023	Change

Net revenues	`$9,738,554`	`$265,259`	`$9,473,295`
Cost of revenue	`7,029,836`	`223,675`	`6,806,161`
Gross profit	`2,708,718`	`41,584`	`2,667,134`

Operating expenses:
Selling, general and administrative	`3,166,743`	`2,125,148`	`1,041,595`
Total operating expenses	`3,166,743`	`2,125,148`	`1,041,595`

Loss from operations	`(458,025)`	`(2,083,564)`	`1,625,539`

Other income (expense):
Interest expense	`(1,441,035)`	`(103,501)`	`(1,337,534)`
Gain on property and equipment	`-`	`9,253`	`(9,253)`
Unrealized loss on marketable securities	`-`	`-`	`-`
Gain on extinguishment of debt	`-`	`13,219`	`(13,219)`
Other income	`-`	`157,502`	`(157,502)`
Interest income	`151`	`157`	`(6)`
Total other income (expense), net	`(1,440,884)`	`76,630`	`(1,517,514)`

Provision for income taxes	`-`	`-`	`-`
Net loss	`$(1,898,909)`	`$(2,006,934)`	`$108,025`

Net Revenues

Revenues increased by $9,473,295 to $9,738,554 for the six months ended June 30, 2024, compared to $265,259 in the corresponding fiscal period in 2023. The increase was primarily due to the acquisition of Ranco in July 2023.

During the six months ended June 30, 2024, the Company realized $38,500 of campaign revenue compared to $216,751 in the corresponding period in 2023. The decrease was primarily due to a shift in efforts during the period to the Ranco Business.

Our revenue for the period June 30, 2024 and 2023 also included $11,559 and $48,508, respectively, relating to sales of product from our e-commerce network focused on the sale of general wellness CBD products.

During the six months ended June 30, 2024, CNP Operating was no longer operating nor generating revenue.

During the six months ended June 30, 2024, the Company’s Ranco subsidiary generated revenue of $9.9 million.

Cost of Revenue

Cost of revenue increased by $6,806,161 to $7,029,836 for the six months ended June 30, 2024, compared to $223,675 in the corresponding fiscal period in 2023. The increase was primarily due to the Ranco business acquired in July 2023.

Operating Expenses

The Company’s operating expenses for the six months ended June 30, 2024 were higher than those in the corresponding period in 2023 due to the acquisition of Ranco in July 2023, including higher payroll, professional fees and travel.

Other Income/Expense

Other income/expenses during the six months ended June 30, 2024 were due to interest expense related to notes payable, which includes amortization of debt discount on Ranco’s notes.

Liquidity, Capital Resources and Going Concern

As of June 30, 2024, we had $225,415 in unrestricted cash and $7,489,389 in notes payable.

Management’s plan to continue as a going concern includes raising capital in the form of debt or equity, growing its existing business acquired under the Ranco Agreement, managing and reducing operating and overhead costs and continuing to pursue strategic transactions and opportunities including launching an e-commerce network focused on the sale of general wellness CBD, products.

Management continues to explore raising additional capital through a combination of debt financing, other non-dilutive financing and/or equity financing to supplement the Company’s capitalization and liquidity. If we raise additional funds by issuing debt securities or preferred stock, or by incurring loans, these forms of financing would have rights, preferences, and privileges senior to those of holders of our Common Stock. The availability and the terms under which we may be able to raise additional capital could be disadvantageous, and the terms of debt financing or other non-dilutive financing may involve restrictive covenants and dilutive financing instruments, which could place significant restrictions on our operations. If we raise capital through the issuance of additional equity, such sales and issuance would dilute the ownership interests of the existing holders of Common Stock. There can be no assurances that any additional debt, other non-dilutive and/or equity financing would be available to us on favorable terms or at all. We expect to continue to incur net losses, comprehensive losses, and negative cash flows from operating activities as we continue to expand our operations to meet anticipated demand.

Cash Flows

The following is a summary of our cash flows from operating, investing and financing activities for the six months ended June 30, 2024:

	Six Months Ended June 30,
	2024	2023
Net cash provided by (used) in operating activities	`$278,790`	`$(564,277)`
Net cash (used in) provided by investing activities	`$(25,979)`	`$608,300`
Net cash provided by (used in) provided by financing activities	`$(105,988)`	`$991,825`

Net cash provided by operating activities was $278,790 during the six months ended June 30, 2024, compared to cash used in operating activities of $(564,277) during the same period in 2023. The increase in cash provided by operating activities was primarily due to increase of accounts payable and accrued expenses and decrease of net loss.

Net cash used in investing activities during the six months ended June 30, 2024 consisted of the sale and purchase of property and equipment.

Net cash used in financing activities during the six months ended June 30, 2024 was $(105,988), including the repayment of notes of $236,155, offset by capital contributions of $130,167. Net cash provided by financing activities during the six months ended June 30, 2023 was $991,825, including proceeds from common stock for $350,000 and proceeds from promissory notes for $1,175,000, partially offset by related party repayments of $2,119 and note repayments of $531,056.

Description of Indebtedness

The Company has recorded the Zingarelli payments during the period as contributions to additional paid in capital through December 31, 2021. This note is currently in default.

Future scheduled maturities of long-term debt are as follows:

		June 30, 2024
2024		`7,362,408`
2025		`8,772`
2026		`8,772`
2027		`8,772`
Thereafter		`100,665`
		`7,489,389`

Obligations Under Preferred Stock

On June 20, 2019, existing debtholders were issued an aggregate of 500 shares of Series A Preferred Stock, each with a stated value per share of $1,000, as conversion of $500,000 worth of outstanding promissory notes. The Series A Preferred Stock bears interest at 12% per annum, and is convertible into our common stock at the election of the holder at a conversion price per share to be mutually agreed between us and the holder in the future, and be redeemable at our option following the third year after issuance, without voting rights or a liquidation preference.

On June 20, 2019, we issued 3,000 shares of Series B Preferred Stock, each with a stated value of $1,000 per share, to Emerging Growth, LLC as part of the Emerging Growth Agreement. The aggregate fair value of $687,000 was recorded as part of the acquisition price of the net assets acquired from Emerging Growth, LLC. The Series B Preferred Stock bears interest at 6% per annum and is convertible into our common stock at the election of Emerging Growth, LLC at a conversion price per share to be mutually agreed between us and Emerging Growth, LLC in the future, without voting rights or a liquidation preference, except with respect to accrued penalty interest.

On May 15, 2023, the Company and Emerging Growth reached an agreement whereby the Company issued 1,620,000 shares of its common stock as payment for $405,000 in outstanding accrued interest on the Series B Preferred Stock through June 30, 2023.

On August 15, 2023, the Company and Emerging Growth reached an agreement whereby the Company issued 500,000 shares of its common stock as payment for $45,000 in outstanding accrued interest on the Series B Preferred Stock through September 30, 2023.

Other Outstanding Obligations at June 30, 2024

Warrants

As of June 30, 2024, 11,988,500 shares of our common stock are issuable pursuant to the exercise of warrants.

Options

As of June 30, 2024, 0 shares of our common stock are issuable pursuant to the exercise of options.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer, who is our principal executive officer and our principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended. Based upon that evaluation, our principal executive officer and principal financial officer concluded that as of June 30, 2024, our disclosure controls and procedures were not effective.

Changes in Internal Control Over Financial Reporting

During the quarter ended June 30, 2024, in order to remediate the segregation of duties and other deficiencies initially created by the departure of our accounting department in June 2019, we hired accounting consultants to perform our account reconciliations and other day-to-day accounting requirements. The internal control structure was also documented and assessed in the areas of financial reporting and disclosure controls as it relates to our continuing operations. In addition, we revised and improved the use of our systems for getting appropriate approvals for purchases and other activities that require authorization. However, our ability to file timely reports is heavily dependent on having the necessary financial resources to pay consultants and other outside service providers involved with performing key elements of our disclosure and financial reporting controls. Our current financial condition, has temporarily hindered our ability to file timely reports for this reason. As a result, we have assessed our disclosure controls and controls over financial reporting as not effective.

PART II - OTHER INFORMATION

Item 6. Exhibits

31.1	Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rule 13a-14(a) and15d-14(a).*

32.1	Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. 1350.**

101.	The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in XBRL (eXtensible Business Reporting Language): (i) the Balance Sheets, (ii) the Statements of Operations, (iii) the Statements of Comprehensive Loss, (iv) the Statements of Changes in Stockholders’ Deficit, (v) the Statements of Cash Flows, and (vi) related notes to these financial statements.*

*Filed herewith.

**Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CFN ENTERPRISES INC.

Dated: August 12, 2024	By:	/s/ Brian Ross
		Brian Ross
		President and Chief Executive Officer
		(Principal Executive Officer and Principal Financial Officer)

Exhibit 31.1

CERTIFICATION

Pursuant to Rule 13a-14(a) and 15d-14(a)

Under the Securities Exchange Act of 1934, as Amended

I, Brian Ross, certify that:

1.I have reviewed this quarterly report on Form 10-Q for the quarter ended June 30, 2024 of CFN Enterprises Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report;

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 12, 2024

/s/ Brian Ross
Brian Ross
President and Chief Executive Officer
(Principal Executive Officer and
Principal Financial Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report (the “Report”) of CFN Enterprises Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof, I, Brian Ross, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 12, 2024


/s/ Brian Ross
Brian Ross
President and Chief Executive Officer
(Principal Executive Officer and Principal Financial Officer)

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2024	Aug. 12, 2024
Details
Registrant CIK	0001352952
Fiscal Year End	--12-31
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Securities Act File Number	000-52635
Entity Registrant Name	CFN ENTERPRISES INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-1559541
Entity Address, Address Line One	600 E. 8TH STREET
Entity Address, City or Town	WHITEFISH
Entity Address, Country	MT
Entity Address, Postal Zip Code	59937
Country Region	833
City Area Code	420
Local Phone Number	2636
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		82,210,664
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current assets
Cash	$ 225,415	$ 78,744
Restricted cash	20,600	20,448
Accounts receivable, net	1,700,632	942,248
Inventory	1,864,703	1,796,227
Total current assets	3,811,350	2,837,667
Property and equipment, net	164,412	156,343
Right of use asset	1,860,574	2,159,043
Deposits	297,269	297,269
Other assets	8,810	8,910
Total assets	6,142,415	5,459,232
Current liabilities
Accounts payable	4,440,176	3,018,531
Accrued liabilities	5,529,570	3,828,063
Due to related party	501,140	501,140
Deferred revenue	235,125	484,212
Current portion of notes payable	7,362,408	7,272,357
Due to seller	1,000,000	1,000,000
Contingent consideration	208,000	208,000
Current portion of right of use liability	394,726	822,259
Current liabilities of discontinued operations	79,823	79,823
Total current liabilities	19,750,968	17,214,385
Right of use liability	1,584,214	1,547,410
Long-term note payable, net of current portion and discounts	126,981	128,443
Total liabilities	21,462,163	18,890,238
Stockholders' deficit
Common shares	82,210	82,210
Additional paid-in capital	61,039,808	60,909,641
Accumulated deficit	(76,441,770)	(74,422,861)
Total stockholders' deficit	(15,319,748)	(13,431,006)
Total liabilities and stockholders' deficit	6,142,415	5,459,232
Series A Preferred Stock
Stockholders' deficit
Preferred shares	1	1
Total stockholders' deficit	1
Series B Preferred Stock
Stockholders' deficit
Preferred shares	3	$ 3
Total stockholders' deficit	$ 3

CONDENSED CONSOLIDATED BALANCE SHEETS - Parenthetical - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Preferred Stock, Par or Stated Value Per Share	$ 0.001
Preferred Stock, Shares Authorized	2,000,000
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	82,210,664	82,210,664
Common Stock, Shares, Outstanding	82,210,664	82,210,664
Series A Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	500	500
Preferred Stock, Shares Issued	500	500
Preferred Stock, Shares Outstanding	500	500
Series B Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	3,000	3,000
Preferred Stock, Shares Issued	3,000	3,000
Preferred Stock, Shares Outstanding	3,000	3,000

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Net revenues	$ 5,893,962	$ 152,301	$ 9,738,554	$ 265,259
Cost of revenue	4,878,001	47,484	7,029,836	223,675
Gross profit	1,015,961	104,817	2,708,718	41,584
Operating expenses
Selling, general and administrative	1,546,949	1,703,134	3,166,743	2,125,148
Total operating expenses	1,546,949	1,703,134	3,166,743	2,125,148
Loss from operations	(530,988)	(1,598,317)	(458,025)	(2,083,564)
Other income (expense)
Interest expense	(720,424)	(37,450)	(1,441,035)	(103,501)
Gain on property and equipment	0	9,253	0	9,253
Gain on extinguishment of debt	0	13,219	0	13,219
Other income	0	157,502	0	157,502
Interest income	74	81	151	157
Total other income (expense), net	(720,350)	142,605	(1,440,884)	76,630
Provision for income taxes	0	0	0	0
Net loss	(1,251,338)	(1,455,712)	(1,898,909)	(2,006,934)
Preferred stock interest	60,000	60,000	120,000	120,000
Net loss available to common shareholders	$ (1,311,338)	$ (1,515,712)	$ (2,018,909)	$ (2,126,934)
Net loss per common share - basic and diluted	$ (0.02)	$ (0.04)	$ (0.02)	$ (0.05)
Weighted average common shares outstanding - basic and diluted	82,210,664	40,846,664	82,210,664	40,255,331

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total	Series A Preferred Stock	Series B Preferred Stock
Shares, Outstanding, Beginning Balance at Dec. 31, 2022	37,690,664				500	3,000
Preferred stock interest	$ 0	$ 0	$ 60,000	$ 60,000	$ 0	$ 0
Stock Issued During Period, Value, New Issues	$ 2,400	597,600	0	600,000	0	0
Stock Issued During Period, Shares, New Issues	2,400,000
Net Income (Loss)	$ 0	0	(551,222)	(551,222)	0	0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2023	$ 40,090	50,383,656	(59,607,321)	(9,183,571)	$ 1	$ 3
Shares, Outstanding, Ending Balance at Mar. 31, 2023	40,090,664				500	3,000
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2022	$ 37,690	49,786,056	(58,996,099)	(9,172,349)	$ 1	$ 3
Preferred stock interest	$ 0	0	(60,000)	(60,000)	$ 0	$ 0
Shares, Outstanding, Beginning Balance at Dec. 31, 2022	37,690,664				500	3,000
Warrants issued with promissory notes				185,788
Preferred stock interest				120,000
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2023	$ 41,710	52,128,924	(61,123,033)	(8,952,396)	$ 1	$ 3
Shares, Outstanding, Ending Balance at Jun. 30, 2023	41,710,664				500	3,000
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2022	$ 37,690	49,786,056	(58,996,099)	(9,172,349)	$ 1	$ 3
Preferred stock interest				(120,000)
Conversion of accrued preferred stock interest into shares				405,000
Stock compensation expense				1,156,100
Proceeds from Contributed Capital				0
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2023	$ 40,090	50,383,656	(59,607,321)	(9,183,571)	$ 1	$ 3
Shares, Outstanding, Beginning Balance at Mar. 31, 2023	40,090,664				500	3,000
Preferred stock interest	$ 0	0	60,000	60,000	$ 0	$ 0
Net Income (Loss)	0	0	(1,455,712)	(1,455,712)	0	0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2023	$ 41,710	52,128,924	(61,123,033)	(8,952,396)	$ 1	$ 3
Shares, Outstanding, Ending Balance at Jun. 30, 2023	41,710,664				500	3,000
Preferred stock interest	$ 0	0	(60,000)	(60,000)	$ 0	$ 0
Conversion of accrued preferred stock interest into shares	$ 1,620	403,380	0	405,000	0	0
Conversion of accrued preferred stock interest into shares Shares	1,620,000
Stock compensation expense	$ 0	1,156,100	0	1,156,100	0	0
Warrants issued in connection with note payable	$ 0	185,788	0	185,788	$ 0	$ 0
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2023				(13,431,006)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023	82,210,664				500	3,000
Preferred stock interest	$ 0	0	60,000	60,000	$ 0	$ 0
Net Income (Loss)	0	0	(647,571)	(647,571)	0	0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2024	$ 82,210	60,980,641	(75,130,432)	(14,067,577)	$ 1	$ 3
Shares, Outstanding, Ending Balance at Mar. 31, 2024	82,210,664				500	3,000
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2023	$ 82,210	60,909,641	(74,422,861)	(13,431,006)	$ 1	$ 3
Preferred stock interest	0	0	(60,000)	(60,000)	0	0
Proceeds from Contributed Capital	$ 0	71,000	0	71,000	$ 0	$ 0
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2023				(13,431,006)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023	82,210,664				500	3,000
Warrants issued with promissory notes				0
Preferred stock interest				120,000
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2024	$ 82,210	61,039,808	(76,441,770)	(15,319,748)	$ 1	$ 3
Shares, Outstanding, Ending Balance at Jun. 30, 2024	82,210,664				500	3,000
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2023	$ 82,210	60,909,641	(74,422,861)	(13,431,006)	$ 1	$ 3
Preferred stock interest				(120,000)
Conversion of accrued preferred stock interest into shares				0
Stock compensation expense				0
Proceeds from Contributed Capital				130,167
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2024	$ 82,210	60,980,641	(75,130,432)	(14,067,577)	$ 1	$ 3
Shares, Outstanding, Beginning Balance at Mar. 31, 2024	82,210,664				500	3,000
Preferred stock interest	$ 0	0	60,000	60,000	$ 0	$ 0
Net Income (Loss)	0	0	(1,251,338)	(1,251,338)	0	0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2024	$ 82,210	61,039,808	(76,441,770)	(15,319,748)	$ 1	$ 3
Shares, Outstanding, Ending Balance at Jun. 30, 2024	82,210,664				500	3,000
Preferred stock interest	$ 0	0	(60,000)	(60,000)	$ 0	$ 0
Proceeds from Contributed Capital	$ 0	$ 59,167	$ 0	$ 59,167	$ 0	$ 0

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities
Net loss	$ (1,898,909)	$ (2,006,934)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	17,910	5,663
Amortization of right of use asset	298,469	29,488
Bad debt expense	432,487	0
Amortization of debt discount	324,744	16,349
Stock compensation expense	0	1,156,100
Gain on property and equipment	0	(9,253)
Gain on extinguishment of debt	0	(13,219)
Changes in operating assets and liabilities
Accounts receivable, net	(1,190,871)	(7,855)
Inventory	(68,476)	0
Prepaid expenses and other assets	100	(8,910)
Accounts payable and accrued expenses	3,003,152	351,937
Deferred revenue	(249,087)	5,349
Payments made in advance of securities date	0	32,500
Right of use liability, net	(390,729)	(115,493)
Net cash provided by (used in) operating activities	278,790	(564,277)
Cash flows from investing activities
Sale of assets held for sale	0	608,300
Purchase of property and equipment, net	(25,979)	0
Net cash (used in) provided by investing activities	(25,979)	608,300
Cash flows from financing activities
Proceeds from (Repayments of) Related Party Debt	0	(2,119)
Proceeds from promissory notes	0	1,175,000
Repayments of Notes Payable	(236,155)	(531,056)
Proceeds from Contributed Capital	130,167	0
Proceeds from sale of common stock	0	350,000
Net cash (used in) provided by financing activities	(105,988)	991,825
Net change in cash and cash equivalents	146,823	1,035,848
Cash and restricted cash at beginning of period	99,192	32,602
Cash and restricted cash at end of period	246,015	1,068,450
Cash at beginning of period	78,744	12,474
Restricted cash at beginning of period	20,448	20,128
Cash and restricted cash at beginning of period	99,192	32,602
Cash at end of period	225,415	1,048,166
Restricted cash at end of period	20,600	20,284
Cash and restricted cash at end of period	246,015	1,068,450
Cash paid for income taxes	0	0
Cash paid for interest	192,500	0
Supplemental disclosure of non-cash investing and financing activities
Accrual of preferred stock interest	120,000	120,000
Warrants issued with promissory notes	0	185,788
Right of use asset and liability	0	187,863
Conversion of accrued preferred stock interest into shares	$ 0	$ 405,000

Note 1 - ORGANIZATION AND BASIS OF PRESENTATION: Organization (Details)	May 15, 2019 USD ($) shares
Stock Issued During Period, Value, Acquisitions \| $	$ 3,000,000
Series B Preferred Stock
Stock Issued During Period, Shares, Acquisitions \| shares	3,000
Common Stock
Stock Issued During Period, Shares, Acquisitions \| shares	30,000,000
Asset Purchased Agreement With Emerging Growth Llc
Payments to Acquire Businesses, Gross \| $	$ 420,000

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Concentration of Credit Risks (Details)	3 Months Ended	6 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)
Cash, FDIC Insured Amount	$ 250,000	$ 250,000
Accounts Receivable
Concentration Risk, Customer		two customers which accounted for 39% of accounts receivable
Revenue Benchmark
Concentration Risk, Customer	one customer accounted for 52% and 33% of the Company’s revenues, respectively	one customer accounted for 52% and 33% of the Company’s revenues, respectively

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Basic and Diluted Earnings Per Share (Details)	Jun. 30, 2024 shares
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	11,988,500
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0

NOTE 3: BUSINESS COMBINATIONS (Details)	3 Months Ended
NOTE 3: BUSINESS COMBINATIONS (Details)	Jun. 30, 2024 USD ($) shares
Issuance of common stock pursuant to business combination \| $	$ 8,000,000
Common Stock
Issuance of common stock pursuant to business combination Shares \| shares	40,000,000

NOTE 3: BUSINESS COMBINATIONS: Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details)	Jun. 30, 2024 USD ($)
Details
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	$ 134,060
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables	175,340
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other	297,269
Business Combination, Recognized Identifiable Assets Acquired AndLiabilities Assumed, Goodwill	8,676,430
Business Combination, Recognized Identifiable Assets Acquired AndLiabilities Assumed, Right of Use Asset	2,272,059
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable	(48,430)
Business Combination, Recognized Identifiable Assets Acquired AndLiabilities Assumed, Right of Use Liability, Current	(538,243)
Business Combination, Recognized Identifiable Assets Acquired AndLiabilities Assumed, Right of Use Liability, Noncurrent	(1,760,485)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	$ 9,208,000

NOTE 3: BUSINESS COMBINATIONS: Business Acquisition, Pro Forma Information (Details)	6 Months Ended
	Jun. 30, 2024 USD ($) $ / shares
Details
Net revenues	$ 2,459,000
Net loss	$ (2,282,313)
Net loss per common share \| $ / shares	$ (0.06)

NOTE 4: PROPERTY AND EQUIPMENT: Property, Plant and Equipment (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment, Gross	$ 252,952	$ 226,973
Less: Accumulated depreciation	(88,540)	(70,630)
Property and equipment, net	164,412	156,343
Machinery and Equipment
Property, Plant and Equipment, Gross	69,270	50,000
Furniture and Fixtures
Property, Plant and Equipment, Gross	14,773	14,773
Retail Site
Property, Plant and Equipment, Gross	$ 168,909	$ 162,200

NOTE 4: PROPERTY AND EQUIPMENT (Details) - USD ($)	3 Months Ended		6 Months Ended
NOTE 4: PROPERTY AND EQUIPMENT (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Details
Depreciation	$ 9,478	$ 2,831	$ 17,910	$ 5,664

NOTE 5: NOTES PAYABLE (Details) - USD ($)							6 Months Ended
NOTE 5: NOTES PAYABLE (Details) - USD ($)	Jul. 01, 2023	May 08, 2023	Nov. 19, 2020	Jun. 24, 2020	Sep. 30, 2019	Sep. 10, 2019	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Oct. 19, 2021	May 12, 2021	Dec. 31, 2019	Oct. 28, 2019
Long-Term Debt							$ 7,489,389
Long-Term Debt, Gross											$ 250,000
Notes Payable												$ 2,957,000
Outstanding Amount												158,625
Balance Paid Per Month												20,000
Total Paid Per Month												138,625
Property and equipment, net							164,412		$ 156,343
Accrued Interest Rate											12.00%
Proceeds from promissory notes							0	$ 1,175,000
Current portion of notes payable							7,362,408		$ 7,272,357
C S B G \| Eagle One
Notes Payable												550,000
C S B G \| Eagl Two
Notes Payable												$ 300,000
CNP Operating
Long-Term Debt, Gross					$ 550,000								$ 3,050,000
Outstanding Balance					$ 302,489		2,218,000							$ 2,218,000
Additional Paid-In Capital Reversal										$ 1,312,080
Debt Instrument, Interest Rate During Period					16.00%
Promissory Note Payable
Proceeds from Long-Term Lines of Credit						$ 500,000
Debt Instrument, Interest Rate, Stated Percentage						8.00%
Debt Instrument, Unamortized Discount						$ 17,624
Long-Term Debt							500,000
Long-Term Debt, Gross							50,000
Promissory Note Payable \| Warrant in Connection with Promissory Note
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						33,333
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 1.5
SBA
Debt Instrument, Interest Rate During Period				3.75%
Proceeds from Loans				$ 150,000
Debt Instrument, Periodic Payment				$ 731
Promissory Note Payable 6
Long-Term Debt							48,513
Debt Instrument, Periodic Payment			$ 968
Property and equipment, net			$ 58,095
Purchase of property and equipment with accounts and notes payable							55,016
Promissory Note Payable 9
Proceeds from Loans		$ 1,150,000
Promissory Note Payable 10
Proceeds from Loans	$ 3,850,000
Ranco Notes
Proceeds from promissory notes							$ 5,000,000

NOTE 5: NOTES PAYABLE: Schedule of Maturities of Long-Term Debt (Details)	Jun. 30, 2024 USD ($)
Details
Long-Term Debt, Maturity, Year Two	$ 7,362,408
Long-Term Debt, Maturity, Year Three	8,772
Long-Term Debt, Maturity, Year Four	8,772
Long-Term Debt, Maturity, Year Five	8,772
Long-Term Debt, Maturity, after Year Five	100,665
Long-Term Debt	$ 7,489,389

NOTE 6: STOCKHOLDERS' DEFICIT (Details) - USD ($)	1 Months Ended	6 Months Ended
NOTE 6: STOCKHOLDERS' DEFICIT (Details) - USD ($)	Jan. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Proceeds from sale of common stock		$ 0	$ 350,000
Preferred Stock, Shares Authorized		2,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001
Dividends, Paid-in-kind		$ 120,000	$ 120,000
Series A Preferred Stock
Preferred Stock, Shares Authorized		500		500
Preferred Stock, Par or Stated Value Per Share		$ 0.001		$ 0.001
Series B Preferred Stock
Preferred Stock, Shares Authorized		3,000		3,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001		$ 0.001
Stock Issuance 2
Shares issued as for exercise of warrant	2,400,000
Proceeds from sale of common stock	$ 600,000

NOTE 6: STOCKHOLDERS' DEFICIT: Schedule of Stockholders' Equity Note, Warrants or Rights (Details) - Warrant	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2024 $ / shares shares	Jun. 30, 2024 $ / shares shares	Dec. 31, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number \| shares	11,988,500	11,988,500	11,988,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value \| $ / shares	$ 0.41	$ 0.41	$ 0.41
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	3 years 8 months 4 days		4 years 2 months 4 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures \| shares		0
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price \| $ / shares		$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Remaining Contractual Term		0
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period \| shares		0
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value \| $ / shares		$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number \| shares	11,988,500	11,988,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price \| $ / shares	$ 0.41	$ 0.41
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term		3 years 8 months 4 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number \| shares	11,988,500	11,988,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price \| $ / shares	$ 0.41	$ 0.41
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term		3 years 8 months 4 days

NOTE 7: LEASES (Details) - USD ($)	6 Months Ended
NOTE 7: LEASES (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Details
Right of use asset and liability	$ 0	$ 187,863

NOTE 7: LEASES: Lessee, Operating Lease, Disclosure (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Details
Right of use asset	$ 1,860,574	$ 2,159,043
Operating Lease, Liability, Current	394,726	822,259
Operating Lease, Liability, Noncurrent	1,584,214	1,547,410
Operating Lease, Liability	$ 1,978,940	$ 2,369,669
Weighted average discount rate	10.00%	10.00%

NOTE 8: RELATED PARTY TRANSACATIONS (Details) - USD ($)	3 Months Ended		6 Months Ended
NOTE 8: RELATED PARTY TRANSACATIONS (Details) - USD ($)	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Details
Due to related party	$ 501,140		$ 501,140		$ 501,140
Proceeds from Contributed Capital	$ 59,167	$ 71,000	$ 130,167	$ 0

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CNFN CFN Enterprises Inc (QB)

CFN Enterprises Inc (QB) News

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%